News | Breast Imaging | April 06, 2018

Guidelines assign special status and approach for African-American and other women at high risk for breast cancer

ACR/SBI Breast Cancer Screening Guidelines Reclassify African-American Women as High-Risk

April 6, 2018 — New American College of Radiology (ACR) and Society of Breast Imaging (SBI) breast cancer screening guidelines are the first to recognize that African-American women are at high-risk for the disease and should be screened as such. The ACR and SBI now call for all women to have a risk assessment at age 30 to see if screening earlier than age 40 is needed. The societies also newly-recommend that women previously diagnosed with breast cancer be screened with magnetic resonance imaging (MRI).

The ACR and SBI continue to recommend that women at average breast cancer risk begin screening at age 40.

“The latest scientific evidence overwhelmingly supports a continued general recommendation of starting annual screening at age 40. It also supports augmented and earlier screening for many women. These updates will help save more lives,” said Debra Monticciolo, M.D., FACR, chair of the American College of Radiology Breast Imaging Commission.

According to 2015 National Cancer Institute Surveillance, Epidemiology and End Results (SEER) data, since mammography became widespread in the 1980s, the U.S. breast cancer death rate in women has dropped 43 percent; it had been unchanged for the previous 50 years. Breast cancer deaths in men, who have the same treatment as women but are not screened, have not declined.

Factors that contributed to the ACR/SBI reclassification of African-American women include that:

  • African-American women are 42 percent more likely to die from breast cancer than non-Hispanic white women despite roughly equal incidence rates;
  • African-American women have a two-fold higher risk of aggressive — “triple-negative” — breast tumors;
  • African-American women are less likely to be diagnosed with stage I breast cancer, but twice as likely to die of early breast cancers; and
  • African-American women have a higher risk of BRCA1 and BRCA2 genetic mutations than those of Western European ancestry. These carriers are at much higher risk for breast cancer.

“Since 1990, breast cancer death rates dropped 23 percent in African-American women — approximately half that in whites. We changed our approach to help save more African-American women and others at higher risk from this deadly disease,” said Wendy B. DeMartini, M.D., FSBI.

For more information: www.endtheconfusion.org

Related Breast Imaging Content

ACR Recommends More Aggressive Breast Cancer Screening for Higher-Than-Average-Risk Women

 


Related Content

News | Breast Imaging

July 29, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the ...

Time July 29, 2024
arrow
News | Breast Imaging

July 29, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time July 29, 2024
arrow
News | Radiology Business

July 25, 2024 — The radiology gender gap is decreasing, but there remains work to be done, according to an editorial ...

Time July 25, 2024
arrow
Videos | Breast Imaging

Don't miss ITN's latest "One on One" video interview with AAWR Past President and American College of Radiology (ACR) ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Flat Panel Displays

July 17, 2024 — LG Electronics (LG) is accelerating its B2B medical device business, expanding its lineup of diagnostic ...

Time July 17, 2024
arrow
Feature | Imaging Technology News - ITN

Be sure to check out the latest digital edition of Imaging Technology News (ITN), featuring the Mobile C-arm Systems ...

Time July 11, 2024
arrow
News | Artificial Intelligence

July 9, 2024 — Lunit, a provider of Artificial Intelligence (AI)-powered solutions for cancer diagnostics and ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
Feature | Radiology Business

The ITN team wishes you a safe and happy 4th of July!

Time July 04, 2024
arrow
Subscribe Now